TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Level 5 - mechanism / opinion, no new human data
Narrative review of molecular signaling mechanisms without primary clinical or empirical data.
PubMed 26993379 · doi:10.1016/j.bcp.2016.03.009
What was done
This narrative review summarizes literature on the molecular mechanisms of the RING finger protein TRAF2 in tumor necrosis factor (TNF) receptor signaling. The authors discuss TRAF2 recruitment to TNFR1 and TNFR2, its dual roles as a molecular scaffold and E3 ubiquitin ligase, its regulation via post-translational modifications, and potential therapeutic strategies targeting TRAF2 in autoimmune diseases and cancer.
What was found
The abstract reports no empirical data or quantitative metrics. It describes qualitative signaling architecture: both TNFR1 and TNFR2 recruit TRAF2 to activate canonical NF-κB and JNK MAP kinase pathways, while TNFR2 additionally stimulates non-canonical NF-κB signaling. TRAF2 coordinates cross-talk between both receptors, functioning as a positive and negative regulator that dictates cell fate decisions between gene expression/survival, apoptosis, or necroptosis.
Why it matters
Clarifying how TRAF2 controls the bifurcation between pro-survival inflammation and cell death pathways helps identify mechanistic targets for modulating TNF signaling in cancer and autoimmune disorders.
Limits
As a narrative review, it contains no primary experimental data, clinical outcomes, or systematic search methodology. Quantitative effect sizes, comparative efficacy of targeting strategies, and human validation are not provided in the abstract.
Cited by
- supports TNF receptors can initiate either a survival signal or a cell death/suicide signal depending on the cellular context.